Jack Phillips - Apr 4, 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Executive Officer, Director
Signature
/s/ David Patience, attorney-in-fact
Stock symbol
AXDX
Transactions as of
Apr 4, 2024
Transactions value $
-$13,981
Form type
4
Date filed
4/5/2024, 04:26 PM
Previous filing
Mar 6, 2024
Next filing
Apr 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +35.5K +46.31% $0.00 112K Apr 4, 2024 Direct F1
transaction AXDX Common Stock Sale -$14K -15.9K -14.16% $0.88 96.3K Apr 4, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -35.5K -40% $0.00 53.3K Apr 4, 2024 Common Stock 35.5K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 4, 2022, the reporting person was granted a total of 88,806 restricted stock units ("RSUs"), of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting.
F2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.